Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study

OBJECTIVE: To determine whether total exposure to penicillin V can be reduced while maintaining adequate clinical efficacy when treating pharyngotonsillitis caused by group A streptococci. DESIGN: Open label, randomised controlled non-inferiority study. SETTING: 17 primary healthcare centres in Swed...

Descripción completa

Detalles Bibliográficos
Autores principales: Skoog Ståhlgren, Gunilla, Tyrstrup, Mia, Edlund, Charlotta, Giske, Christian G, Mölstad, Sigvard, Norman, Christer, Rystedt, Karin, Sundvall, Pär-Daniel, Hedin, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776830/
https://www.ncbi.nlm.nih.gov/pubmed/31585944
http://dx.doi.org/10.1136/bmj.l5337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776830/
https://www.ncbi.nlm.nih.gov/pubmed/31585944
http://dx.doi.org/10.1136/bmj.l5337

Ejemplares similares